Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.

Colgate-Palmolive's adjusted EPS reached $0.91, exceeding analyst expectations of $0.89. Revenue fell slightly short at $4.944 billion compared to the $4.98 billion estimate. The company ...

Consumer goods manufacturer Colgate-Palmolive (NYSE:CL) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91 ...

Colgate-Palmolive (NYSE:CL), a global leader in consumer products, has demonstrated resilience in the face of economic headwinds and market volatility. The company's strong brand portfolio and ...

Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.

Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue milestone in 2024 Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting ...

Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...

In a report released today, Mark Astrachan from Stifel Nicolaus maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a ...

Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.